Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Trial of Rapamycin Plus Estradiol-Eluting Stents Versus Rapamycin-Eluting Stents For The Reduction of Coronary Restenosis (ISAR-PEACE)

NCT00402636 is registered in ClinicalTrials.gov with Deutsches Herzzentrum Muenchen as lead sponsor.

NCT NCT00402636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00402636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Trial of Rapamycin Plus Estradiol-Eluting Stents Versus Rapamycin-Eluting Stents For The Reduction of Coronary Restenosis (ISAR-PEACE)
Lead sponsor
Deutsches Herzzentrum Muenchen
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2005
Completion date
October 31, 2006
Enrollment
502 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease